JP2008505705A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008505705A5 JP2008505705A5 JP2007520493A JP2007520493A JP2008505705A5 JP 2008505705 A5 JP2008505705 A5 JP 2008505705A5 JP 2007520493 A JP2007520493 A JP 2007520493A JP 2007520493 A JP2007520493 A JP 2007520493A JP 2008505705 A5 JP2008505705 A5 JP 2008505705A5
- Authority
- JP
- Japan
- Prior art keywords
- medical device
- drug
- catheter
- antiproliferative
- antiplatelet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims 11
- 229940079593 drug Drugs 0.000 claims 10
- 239000003814 drug Substances 0.000 claims 10
- 230000001028 anti-proliverative effect Effects 0.000 claims 9
- 239000000203 mixture Substances 0.000 claims 9
- 229940127218 antiplatelet drug Drugs 0.000 claims 8
- 238000000502 dialysis Methods 0.000 claims 8
- 229920000642 polymer Polymers 0.000 claims 8
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 239000000463 material Substances 0.000 claims 3
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 claims 3
- 230000002792 vascular Effects 0.000 claims 3
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 claims 2
- 102000009123 Fibrin Human genes 0.000 claims 2
- 108010073385 Fibrin Proteins 0.000 claims 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 claims 2
- 229930012538 Paclitaxel Natural products 0.000 claims 2
- 229920002732 Polyanhydride Polymers 0.000 claims 2
- 229920000331 Polyhydroxybutyrate Polymers 0.000 claims 2
- 239000003146 anticoagulant agent Substances 0.000 claims 2
- 229940127219 anticoagulant drug Drugs 0.000 claims 2
- 239000004019 antithrombin Substances 0.000 claims 2
- 238000013270 controlled release Methods 0.000 claims 2
- 229950003499 fibrin Drugs 0.000 claims 2
- 229940125672 glycoprotein IIb/IIIa inhibitor Drugs 0.000 claims 2
- 229960001592 paclitaxel Drugs 0.000 claims 2
- 239000005015 poly(hydroxybutyrate) Substances 0.000 claims 2
- 229920000747 poly(lactic acid) Polymers 0.000 claims 2
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims 2
- 229940065514 poly(lactide) Drugs 0.000 claims 2
- 229920001610 polycaprolactone Polymers 0.000 claims 2
- 239000004632 polycaprolactone Substances 0.000 claims 2
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 claims 2
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 claims 2
- 229960002930 sirolimus Drugs 0.000 claims 2
- 230000001464 adherent effect Effects 0.000 claims 1
- 238000002617 apheresis Methods 0.000 claims 1
- 229920002988 biodegradable polymer Polymers 0.000 claims 1
- 239000004621 biodegradable polymer Substances 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000000824 cytostatic agent Substances 0.000 claims 1
- 230000001085 cytostatic effect Effects 0.000 claims 1
- 230000008384 membrane barrier Effects 0.000 claims 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims 1
- 125000002456 taxol group Chemical group 0.000 claims 1
- 229940070710 valerate Drugs 0.000 claims 1
- 229940005605 valeric acid Drugs 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/887,272 US20050084514A1 (en) | 2000-11-06 | 2004-07-08 | Combination drug therapy for reducing scar tissue formation |
| PCT/US2005/024076 WO2006014534A2 (en) | 2004-07-08 | 2005-07-07 | Combination drug therapy for reducing scar tissue formation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008184851A Division JP2009022759A (ja) | 2004-07-08 | 2008-07-16 | 瘢痕組織形成を軽減するための併用薬物治療 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008505705A JP2008505705A (ja) | 2008-02-28 |
| JP2008505705A5 true JP2008505705A5 (enExample) | 2008-08-21 |
Family
ID=35787643
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007520493A Pending JP2008505705A (ja) | 2004-07-08 | 2005-07-07 | 瘢痕組織形成を軽減するための併用薬物治療 |
| JP2008184851A Pending JP2009022759A (ja) | 2004-07-08 | 2008-07-16 | 瘢痕組織形成を軽減するための併用薬物治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008184851A Pending JP2009022759A (ja) | 2004-07-08 | 2008-07-16 | 瘢痕組織形成を軽減するための併用薬物治療 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20050084514A1 (enExample) |
| EP (2) | EP1844734A3 (enExample) |
| JP (2) | JP2008505705A (enExample) |
| CN (2) | CN101014299A (enExample) |
| AU (1) | AU2005269902A1 (enExample) |
| BR (1) | BRPI0512604A (enExample) |
| CA (2) | CA2572963A1 (enExample) |
| MX (1) | MXPA06015259A (enExample) |
| NZ (1) | NZ561597A (enExample) |
| WO (1) | WO2006014534A2 (enExample) |
Families Citing this family (99)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6955661B1 (en) * | 1999-01-25 | 2005-10-18 | Atrium Medical Corporation | Expandable fluoropolymer device for delivery of therapeutic agents and method of making |
| JP2006515186A (ja) * | 2002-09-26 | 2006-05-25 | アンジオテック インターナショナル アクツィエン ゲゼルシャフト | 血管周囲ラップ |
| US8021331B2 (en) * | 2003-09-15 | 2011-09-20 | Atrium Medical Corporation | Method of coating a folded medical device |
| JP2007505932A (ja) * | 2003-09-18 | 2007-03-15 | マクサイト， インコーポレイテッド | 経強膜送達 |
| AU2004291062A1 (en) * | 2003-11-10 | 2005-06-02 | Angiotech International Ag | Medical implants and anti-scarring agents |
| US20050158356A1 (en) * | 2003-11-20 | 2005-07-21 | Angiotech International Ag | Implantable sensors and implantable pumps and anti-scarring agents |
| US8124127B2 (en) | 2005-10-15 | 2012-02-28 | Atrium Medical Corporation | Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings |
| US9012506B2 (en) | 2004-09-28 | 2015-04-21 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
| US9592324B2 (en) * | 2006-11-06 | 2017-03-14 | Atrium Medical Corporation | Tissue separating device with reinforced support for anchoring mechanisms |
| US9801982B2 (en) * | 2004-09-28 | 2017-10-31 | Atrium Medical Corporation | Implantable barrier device |
| WO2006037049A2 (en) | 2004-09-28 | 2006-04-06 | Atrium Medical Corporation | Application of a coating on a medical device |
| US20060083768A1 (en) * | 2004-09-28 | 2006-04-20 | Atrium Medical Corporation | Method of thickening a coating using a drug |
| US20090011116A1 (en) * | 2004-09-28 | 2009-01-08 | Atrium Medical Corporation | Reducing template with coating receptacle containing a medical device to be coated |
| WO2007011385A2 (en) * | 2004-09-28 | 2007-01-25 | Atrium Medical Corporation | Heat cured gel and method of making |
| US8367099B2 (en) | 2004-09-28 | 2013-02-05 | Atrium Medical Corporation | Perforated fatty acid films |
| US8312836B2 (en) * | 2004-09-28 | 2012-11-20 | Atrium Medical Corporation | Method and apparatus for application of a fresh coating on a medical device |
| US9000040B2 (en) | 2004-09-28 | 2015-04-07 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
| US20060121004A1 (en) * | 2004-12-07 | 2006-06-08 | Yann Echelard | Methods of reducing the incidence of rejection in tissue transplantation through the use of recombinant human antithrombin |
| US8663639B2 (en) * | 2005-02-09 | 2014-03-04 | Santen Pharmaceutical Co., Ltd. | Formulations for treating ocular diseases and conditions |
| WO2006086750A1 (en) * | 2005-02-09 | 2006-08-17 | Macusight, Inc. | Liquid formulations for treatment of diseases or conditions |
| WO2006123226A2 (en) * | 2005-05-18 | 2006-11-23 | De Villiers, Malan | An inhibitor of mtor for inhibiting the formation of scar tissue |
| US20090062909A1 (en) | 2005-07-15 | 2009-03-05 | Micell Technologies, Inc. | Stent with polymer coating containing amorphous rapamycin |
| KR101406415B1 (ko) | 2005-07-15 | 2014-06-19 | 미셀 테크놀로지즈, 인코포레이티드 | 제어된 형태의 약물 분말을 함유하는 중합체 코팅 |
| GB0515003D0 (en) | 2005-07-21 | 2005-08-31 | Univ Aston | Medical devices and coatings therefor |
| US9427423B2 (en) * | 2009-03-10 | 2016-08-30 | Atrium Medical Corporation | Fatty-acid based particles |
| US9278161B2 (en) | 2005-09-28 | 2016-03-08 | Atrium Medical Corporation | Tissue-separating fatty acid adhesion barrier |
| US8492400B2 (en) | 2006-02-09 | 2013-07-23 | Santen Pharmaceutical Co., Ltd. | Stable formulations, and methods of their preparation and use |
| CN101443004B (zh) * | 2006-03-23 | 2013-03-06 | 参天制药株式会社 | 用于与血管通透性有关的疾病或病症的制剂 |
| CA2996768C (en) | 2006-04-26 | 2020-12-08 | Micell Technologies, Inc. | Coatings containing multiple drugs |
| US7722665B2 (en) * | 2006-07-07 | 2010-05-25 | Graft Technologies, Inc. | System and method for providing a graft in a vascular environment |
| US20080039362A1 (en) * | 2006-08-09 | 2008-02-14 | Afmedica, Inc. | Combination drug therapy for reducing scar tissue formation |
| CA2667228C (en) | 2006-10-23 | 2015-07-14 | Micell Technologies, Inc. | Holder for electrically charging a substrate during coating |
| US9492596B2 (en) * | 2006-11-06 | 2016-11-15 | Atrium Medical Corporation | Barrier layer with underlying medical device and one or more reinforcing support structures |
| US20080152784A1 (en) * | 2006-12-22 | 2008-06-26 | Boston Scientific Scimed, Inc. | Methods of manufacturing coatings and coated medical devices |
| US11426494B2 (en) | 2007-01-08 | 2022-08-30 | MT Acquisition Holdings LLC | Stents having biodegradable layers |
| CN101711137B (zh) | 2007-01-08 | 2014-10-22 | 米歇尔技术公司 | 具有可生物降解层的支架 |
| US7938286B2 (en) * | 2007-02-13 | 2011-05-10 | Gateway Plastics, Inc. | Container system |
| US9433516B2 (en) | 2007-04-17 | 2016-09-06 | Micell Technologies, Inc. | Stents having controlled elution |
| US20080265343A1 (en) * | 2007-04-26 | 2008-10-30 | International Business Machines Corporation | Field effect transistor with inverted t shaped gate electrode and methods for fabrication thereof |
| WO2008148013A1 (en) | 2007-05-25 | 2008-12-04 | Micell Technologies, Inc. | Polymer films for medical device coating |
| US8075908B2 (en) | 2007-08-17 | 2011-12-13 | Anhese Llc | Apparatus and method for reducing the occurrence of post-surgical adhesions |
| WO2009067711A2 (en) | 2007-11-21 | 2009-05-28 | T.J. Smith & Nephew, Limited | Suction device and dressing |
| CN104382691B (zh) | 2007-11-21 | 2018-08-31 | 史密夫及内修公开有限公司 | 伤口包敷物 |
| GB0722820D0 (en) | 2007-11-21 | 2008-01-02 | Smith & Nephew | Vacuum assisted wound dressing |
| GB0723875D0 (en) | 2007-12-06 | 2008-01-16 | Smith & Nephew | Wound management |
| US11253399B2 (en) | 2007-12-06 | 2022-02-22 | Smith & Nephew Plc | Wound filling apparatuses and methods |
| US20130096518A1 (en) | 2007-12-06 | 2013-04-18 | Smith & Nephew Plc | Wound filling apparatuses and methods |
| US20090156772A1 (en) * | 2007-12-12 | 2009-06-18 | Boston Scientific Scimed, Inc. | Melt processed materials for medical articles |
| GB0803564D0 (en) | 2008-02-27 | 2008-04-02 | Smith & Nephew | Fluid collection |
| JP5608160B2 (ja) | 2008-04-17 | 2014-10-15 | ミセル テクノロジーズ、インコーポレイテッド | 生体吸収性の層を有するステント |
| EP2313122B1 (en) | 2008-07-17 | 2019-03-06 | Micell Technologies, Inc. | Drug delivery medical device |
| WO2010030585A1 (en) * | 2008-09-11 | 2010-03-18 | Noble Fiber Technologies, Llc | Foam with antimicrobial and hemostatic agents |
| KR101062068B1 (ko) * | 2008-12-01 | 2011-09-02 | 포항공과대학교 산학협력단 | 유착방지용 조성물 |
| US8834913B2 (en) | 2008-12-26 | 2014-09-16 | Battelle Memorial Institute | Medical implants and methods of making medical implants |
| KR20110110265A (ko) | 2008-12-29 | 2011-10-06 | 신세스 게엠바하 | 수술 부위의 보존을 위한 막 조성물의 형성 방법 및 결과적으로 얻어진 막조성물 |
| GB0902816D0 (en) | 2009-02-19 | 2009-04-08 | Smith & Nephew | Fluid communication path |
| WO2010097477A2 (en) * | 2009-02-27 | 2010-09-02 | Ludwig-Maximilians-Universität München | Means and methods of preserving grafts |
| JP2012522589A (ja) | 2009-04-01 | 2012-09-27 | ミシェル テクノロジーズ，インコーポレイテッド | 被覆ステント |
| DE102009030931A1 (de) | 2009-06-24 | 2010-12-30 | Eberhard-Karls-Universität Tübingen Universitätsklinikum | Chirurgisches Wundverschlusselement |
| EP2453834A4 (en) | 2009-07-16 | 2014-04-16 | Micell Technologies Inc | MEDICAL DEVICE DISPENSING MEDICINE |
| US20110038910A1 (en) | 2009-08-11 | 2011-02-17 | Atrium Medical Corporation | Anti-infective antimicrobial-containing biomaterials |
| EP2531140B1 (en) | 2010-02-02 | 2017-11-01 | Micell Technologies, Inc. | Stent and stent delivery system with improved deliverability |
| US8795762B2 (en) | 2010-03-26 | 2014-08-05 | Battelle Memorial Institute | System and method for enhanced electrostatic deposition and surface coatings |
| US10232092B2 (en) | 2010-04-22 | 2019-03-19 | Micell Technologies, Inc. | Stents and other devices having extracellular matrix coating |
| US9061095B2 (en) | 2010-04-27 | 2015-06-23 | Smith & Nephew Plc | Wound dressing and method of use |
| GB201011173D0 (en) | 2010-07-02 | 2010-08-18 | Smith & Nephew | Provision of wound filler |
| EP2593039B1 (en) | 2010-07-16 | 2022-11-30 | Micell Technologies, Inc. | Drug delivery medical device |
| EP2593141B1 (en) | 2010-07-16 | 2018-07-04 | Atrium Medical Corporation | Composition and methods for altering the rate of hydrolysis of cured oil-based materials |
| CA2810842C (en) | 2010-09-09 | 2018-06-26 | Micell Technologies, Inc. | Macrolide dosage forms |
| US8900616B2 (en) | 2010-10-22 | 2014-12-02 | Covidien Lp | System and method for satellite drug delivery |
| GB201020005D0 (en) | 2010-11-25 | 2011-01-12 | Smith & Nephew | Composition 1-1 |
| CN107033596A (zh) | 2010-11-25 | 2017-08-11 | 史密夫及内修公开有限公司 | 组合物i – ii及其产品和用途 |
| KR101248368B1 (ko) * | 2011-05-24 | 2013-04-01 | 서울대학교산학협력단 | 약물이 탑재된 고분자 필름을 포함하는 봉합사 및 이의 제조방법 |
| WO2012166819A1 (en) | 2011-05-31 | 2012-12-06 | Micell Technologies, Inc. | System and process for formation of a time-released, drug-eluting transferable coating |
| CA2841360A1 (en) | 2011-07-15 | 2013-01-24 | Micell Technologies, Inc. | Drug delivery medical device |
| US10188772B2 (en) | 2011-10-18 | 2019-01-29 | Micell Technologies, Inc. | Drug delivery medical device |
| US20150159066A1 (en) | 2011-11-25 | 2015-06-11 | Smith & Nephew Plc | Composition, apparatus, kit and method and uses thereof |
| US20150087671A1 (en) * | 2012-05-16 | 2015-03-26 | Micell Technologies, Inc. | Low burst sustained release lipophilic and biologic agent compositions |
| US9867880B2 (en) | 2012-06-13 | 2018-01-16 | Atrium Medical Corporation | Cured oil-hydrogel biomaterial compositions for controlled drug delivery |
| US9132025B2 (en) | 2012-06-15 | 2015-09-15 | Trivascular, Inc. | Bifurcated endovascular prosthesis having tethered contralateral leg |
| US10881839B2 (en) | 2012-10-26 | 2021-01-05 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
| US10806830B2 (en) | 2012-10-26 | 2020-10-20 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
| US10898700B2 (en) | 2012-10-26 | 2021-01-26 | Urotronic, Inc. | Balloon catheters for body lumens |
| US11504450B2 (en) | 2012-10-26 | 2022-11-22 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
| EP2967803B1 (en) | 2013-03-12 | 2023-12-27 | Micell Technologies, Inc. | Bioabsorbable biomedical implants |
| EP2968647B1 (en) | 2013-03-15 | 2022-06-29 | Smith & Nephew plc | Wound dressing sealant and use thereof |
| US20160120706A1 (en) | 2013-03-15 | 2016-05-05 | Smith & Nephew Plc | Wound dressing sealant and use thereof |
| EP2996629B1 (en) | 2013-05-15 | 2021-09-22 | Micell Technologies, Inc. | Bioabsorbable biomedical implants |
| US9936954B2 (en) | 2014-06-10 | 2018-04-10 | Ethicon Llc | Devices and methods for sealing staples in tissue |
| WO2016130485A1 (en) * | 2015-02-09 | 2016-08-18 | The Board Of Regents Of The University Of Texas System | Use of mtor inhibitors to prevent and regress adhesions and fibrosis |
| US11904072B2 (en) | 2015-04-24 | 2024-02-20 | Urotronic, Inc. | Drug coated balloon catheters for nonvascular strictures |
| EP3115031B1 (en) * | 2015-07-06 | 2021-12-22 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Intraocular device and method for preparing the same |
| EP3337408B1 (en) * | 2015-08-18 | 2023-01-18 | CorMedix Inc. | Antimicrobial wound closure materials, including antimicrobial sutures, and method for closing a wound using the same |
| WO2019044765A1 (ja) * | 2017-08-28 | 2019-03-07 | 川澄化学工業株式会社 | 癒着防止材 |
| US11692037B2 (en) * | 2017-10-20 | 2023-07-04 | Hyogo College Of Medicine | Anti-IL-6 receptor antibody-containing medicinal composition for preventing post-surgical adhesion |
| IT201800004220A1 (it) * | 2018-04-05 | 2019-10-05 | Dispositivo impiantabile per la somministrazione localizzata di farmaci, suoi usi e suo procedimento di fabbricazione. | |
| EP4223352A3 (en) | 2019-02-22 | 2023-11-01 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
| CN115052644A (zh) * | 2020-02-14 | 2022-09-13 | 萩原明郎 | 血管吻合部的保护套 |
| CN117479893A (zh) * | 2021-04-13 | 2024-01-30 | 爱惜康股份有限公司 | 具有包含药物的外部细丝的缝合线 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3414967C2 (de) * | 1984-04-19 | 1986-06-05 | Effem Gmbh, 2810 Verden | Verfahren zum Herstellen eines Leichtkeramikmaterials für Bauzwecke und Verwendung dieses Materials |
| US6326017B1 (en) * | 1989-10-02 | 2001-12-04 | University Of Washington | Methods for the localized delivery of agents to blood vessels |
| US5239113A (en) * | 1991-10-15 | 1993-08-24 | Monsanto Company | Substituted β-amino acid derivatives useful as platelet aggregation inhibitors and intermediates thereof |
| US5516781A (en) * | 1992-01-09 | 1996-05-14 | American Home Products Corporation | Method of treating restenosis with rapamycin |
| US5681278A (en) * | 1994-06-23 | 1997-10-28 | Cormedics Corp. | Coronary vasculature treatment method |
| US5563145A (en) * | 1994-12-07 | 1996-10-08 | American Home Products Corporation | Rapamycin 42-oximes and hydroxylamines |
| US5767135A (en) * | 1995-12-29 | 1998-06-16 | Fernandez-Pol; Jose Alberto | Antiviral agent |
| US5893839A (en) * | 1997-03-13 | 1999-04-13 | Advanced Research And Technology Institute, Inc. | Timed-release localized drug delivery by percutaneous administration |
| DE19713214A1 (de) * | 1997-03-28 | 1998-12-10 | Ruebben Alexander Dr Med | Covered Stent zur verlängerten Offenhaltung von Hohlorganen oder der Behandlung von Gefäßaneurysmen |
| CA2364252A1 (en) * | 1999-03-11 | 2000-09-14 | Bristol-Myers Squibb Pharma Company | Synergy between low molecular weight heparin and platelet aggregation inhibitors, providing a combination therapy for the prevention and treatment of various thromboembolic disorders |
| US20040241211A9 (en) * | 2000-11-06 | 2004-12-02 | Fischell Robert E. | Devices and methods for reducing scar tissue formation |
| US20040018228A1 (en) * | 2000-11-06 | 2004-01-29 | Afmedica, Inc. | Compositions and methods for reducing scar tissue formation |
| AU2002249958B2 (en) * | 2001-01-16 | 2007-11-08 | Vascular Therapies, Inc. | Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts |
| US20030216758A1 (en) * | 2001-12-28 | 2003-11-20 | Angiotech Pharmaceuticals, Inc. | Coated surgical patches |
| HUP0402594A3 (en) * | 2002-01-10 | 2006-01-30 | Novartis Ag | Drug delivery systems for the prevention and treatment of vascular diseases comprising rapamycin and derivatives thereof |
| US6755824B2 (en) * | 2002-04-15 | 2004-06-29 | Uab Research Foundation | Platelet inhibitor eluting ablation catheter |
| US20030199457A1 (en) * | 2002-04-17 | 2003-10-23 | El-Naggar Mawaheb M. | Prevention and treatment of thromboembolic disorders associated with arterial & venous thrombosis |
| IES20030298A2 (en) * | 2002-04-23 | 2003-10-29 | R Stephen Porter | Inhibition of platelet aggregation |
| EP1505931A1 (en) * | 2002-05-20 | 2005-02-16 | Orbus Medical Technologies, Inc. | Drug eluting implantable medical device |
| US20040002755A1 (en) * | 2002-06-28 | 2004-01-01 | Fischell David R. | Method and apparatus for treating vulnerable coronary plaques using drug-eluting stents |
| US20040170685A1 (en) * | 2003-02-26 | 2004-09-02 | Medivas, Llc | Bioactive stents and methods for use thereof |
-
2004
- 2004-07-08 US US10/887,272 patent/US20050084514A1/en not_active Abandoned
-
2005
- 2005-07-07 CN CNA2005800260402A patent/CN101014299A/zh active Pending
- 2005-07-07 BR BRPI0512604-5A patent/BRPI0512604A/pt not_active IP Right Cessation
- 2005-07-07 EP EP07015123A patent/EP1844734A3/en not_active Withdrawn
- 2005-07-07 AU AU2005269902A patent/AU2005269902A1/en not_active Abandoned
- 2005-07-07 CN CNA2007101860895A patent/CN101164617A/zh active Pending
- 2005-07-07 CA CA002572963A patent/CA2572963A1/en not_active Abandoned
- 2005-07-07 MX MXPA06015259A patent/MXPA06015259A/es not_active Application Discontinuation
- 2005-07-07 JP JP2007520493A patent/JP2008505705A/ja active Pending
- 2005-07-07 EP EP05770337A patent/EP1768602A4/en not_active Withdrawn
- 2005-07-07 CA CA002638747A patent/CA2638747A1/en not_active Abandoned
- 2005-07-07 WO PCT/US2005/024076 patent/WO2006014534A2/en not_active Ceased
- 2005-07-07 NZ NZ561597A patent/NZ561597A/en unknown
-
2008
- 2008-07-16 JP JP2008184851A patent/JP2009022759A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6172725B2 (ja) | 少なくとも１種のポリエステルブロック及びポリ（エチレングリコール）ブロックを含むブロックコポリマー | |
| CN108551759B (zh) | 药物洗脱支架和使用其用于使功能性内皮细胞层恢复的方法 | |
| JP5659445B2 (ja) | ポリ（エチレングリコール）−ポリ（ラクチド−グリコリド−カプロラクトン）相互貫入ネットワークを含むコーティング物 | |
| JP5982688B2 (ja) | 埋込み型デバイス用の吸収性コーティング | |
| JP5732659B2 (ja) | 低速溶解ポリマーを有する埋込型デバイス | |
| ES2451653T3 (es) | Dispositivo médico implantable con revestimiento de suministro de fármacos de poliéster de erosión superficial | |
| JP5463003B2 (ja) | 医療用生体分解性組成物 | |
| JP5579705B2 (ja) | 非晶質下塗り層及び半結晶性貯蔵層を含むコーティング | |
| JP5602432B2 (ja) | 経皮的冠動脈インターベンション用の多剤溶出冠動脈ステント | |
| WO2011008883A1 (en) | Biodegradable self-expanding prosthesis | |
| JP6103606B2 (ja) | カプロラクトン及びグリコリドを含むターポリマーを含むコーティング | |
| JP2012500660A (ja) | 生分解性エラストマ及び放出可能なタキサン剤をコーティングした埋込み医療器具 | |
| CN101631514A (zh) | 用于经皮冠状动脉介入的多药物洗脱冠状动脉支架 | |
| MX2012013753A (es) | Recubrimiento de endoprotesis con un recubrimiento que consiste de una malla ajustada de fibras de polimero. | |
| JP6052687B2 (ja) | 非晶質ターポリマー及び半結晶性ブロックを含むポリマー | |
| JP2013227505A (ja) | ホスホリルコリン基を含有する共重合体とその製造及び利用方法 | |
| JP2011500282A (ja) | ラクチド及びグリコリドを含有するランダム非晶質ターポリマー | |
| JP5102200B2 (ja) | 生体内留置物 | |
| US20080169582A1 (en) | Method and apparatus for making polymeric drug delivery devices having differing morphological structures | |
| Fan et al. | A review on pancreatic duct stents: Materials and emerging trends | |
| JPWO2007116646A1 (ja) | 生体内留置物 | |
| Nuge et al. | Advances and Issues in Biomaterials for Coronary Stenting | |
| HK1259282B (zh) | 药物洗脱支架和使用其用於使功能性内皮细胞层恢复的方法 |